8-K Announcements
6Material company update
Mar 26, 2026·SEC
Material company update
Mar 13, 2026·SEC
Material company update
Nov 7, 2025·SEC
SANUWAVE Health, Inc.(SNWV)Earnings, Financials & Key Ratios
SNWV•NASDAQ
$15.92
$137M mkt cap·Price updated May 6, 2026
AboutSANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Show more
- Revenue$33M+60.0%
- EBITDA$7M+1244.7%
- Net Income-$31M-21.6%
- EPS (Diluted)-7.03+42.3%
- Gross Margin75.23%+6.8%
- EBITDA Margin20.11%+740.5%
- Operating Margin16.6%+727.0%
- Net Margin-96.13%+24.0%
- ROIC159.82%
- Interest Coverage0.40+1249.3%
SNWV Key Insights
SANUWAVE Health, Inc. (SNWV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓Strong 5Y sales CAGR of 99.7%
- ✓Efficient asset utilization: 1.1x turnover
✗Weaknesses
- ✗Weak momentum: RS Rating 6 (bottom 6%)
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SNWV Price & Volume
SANUWAVE Health, Inc. (SNWV) stock price & volume — 10-year historical chart
Loading chart...
SNWV Growth Metrics
SANUWAVE Health, Inc. (SNWV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years44.07%
5 Years99.65%
3 Years35.87%
TTM40.89%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-1710.8%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-1484.94%
Return on Capital
10 Years159.82%
5 Years159.82%
3 Years159.82%
Last Year159.82%
SNWV Recent Earnings
SANUWAVE Health, Inc. (SNWV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (67%)●Beat Revenue 1/12 qtrs (33%)
Q2 2026Latest
Mar 26, 2026EPS
$0.03
Est $0.17
-82.4%
Revenue
$13M
Est $13M
+1.1%
Q4 2025
Nov 7, 2025EPS
$0.46
Est $0.32
+43.8%
Revenue
$11M
Est $13M
-13.4%
Q3 2025
Aug 8, 2025EPS
$0.01
Est $0.09
+111.1%
Revenue
$10M
Est $13M
-18.8%
Q2 2025
May 9, 2025EPS
$0.66
Revenue
$9M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 26, 2026 | $0.03vs $0.17-82.4% | $13Mvs $13M+1.1% |
| Q4 2025 | Nov 7, 2025 | $0.46vs $0.32+43.8% | $11Mvs $13M-13.4% |
| Q3 2025 | Aug 8, 2025 | $0.01vs $0.09+111.1% | $10Mvs $13M-18.8% |
| Q2 2025 | May 9, 2025 | $0.66 | $9M |
Based on last 12 quarters of dataView full earnings history →
SNWV Peer Comparison
SANUWAVE Health, Inc. (SNWV) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MLSS | 31.69M | 0.40 | -6.83 | -12.19% | -76.78% | -208.8% | 0.06 | |
 XTNT | 80.8M | 0.58 | -4.81 | 28.44% | 1.32% | 3.77% | 0.82 | |
 LNTH | 5.61B | 86.15 | 25.26 | 0.5% | 15.15% | 20.58% | 0.00 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ANIK | 202.62M | 15.12 | -19.89 | -5.91% | -9.52% | -7.74% | 0.17 | |
 OSUR | 215.9M | 3.00 | -3.19 | -38.1% | -61.93% | -19.46% | 0.04 | |
 CNMD | 1.15B | 37.32 | 24.72 | 5.16% | 4% | 5.4% | 0.81 | |
 MMSI | 3.68B | 61.63 | 28.93 | 11.66% | 9.03% | 8.95% | 0.57 |
Compare SNWV vs Peers
SANUWAVE Health, Inc. (SNWV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SNWV Income Statement
SANUWAVE Health, Inc. (SNWV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.38M | 738.53K | 1.85M | 1.03M | 4.06M | 13.01M | 16.74M | 20.4M | 32.63M | 41.28M |
| Revenue Growth % | 42.52% | -46.33% | 150.51% | -44.39% | 294.37% | 220.68% | 28.69% | 21.84% | 59.99% | 40.89% |
| Cost of Goods Sold | 565.13K | 241.97K | 693.66K | 538.92K | 1.16M | 4.99M | 4.33M | 6.04M | 8.08M | 9.2M |
| COGS % of Revenue | 41.07% | 32.76% | 37.49% | 52.39% | 28.64% | 38.32% | 25.87% | 29.59% | 24.77% | - |
| Gross Profit | 810.93K▲ 0% | 496.56K▼ 38.8% | 1.16M▲ 132.9% | 489.81K▼ 57.6% | 2.9M▲ 491.0% | 8.02M▲ 177.2% | 12.41M▲ 54.7% | 14.36M▲ 15.7% | 24.55M▲ 70.9% | 32.09M▲ 0% |
| Gross Margin % | 58.93% | 67.24% | 62.51% | 47.61% | 71.36% | 61.68% | 74.13% | 70.41% | 75.23% | 77.72% |
| Gross Profit Growth % | 19.16% | -38.77% | 132.88% | -57.64% | 491.05% | 177.17% | 54.67% | 15.73% | 70.93% | - |
| Operating Expenses | 4.13M | 4.32M | 8.34M | 9.28M | 28.09M | 22.17M | 21.36M | 14.9M | 19.13M | 25.23M |
| OpEx % of Revenue | 300.06% | 585.08% | 450.62% | 902.49% | 692.51% | 170.38% | 127.6% | 73.06% | 58.63% | - |
| Selling, General & Admin | 2.67M | 3M | 7.33M | 8.03M | 18.88M | 20.28M | 20.03M | 13.57M | 17.67M | 23.75M |
| SG&A % of Revenue | 194.31% | 406.81% | 396.35% | 780.68% | 465.44% | 155.89% | 119.64% | 66.54% | 54.15% | - |
| Research & Development | 1.13M | 1.29M | 1.66M | 1.18M | 1.25M | 1.1M | 567K | 579K | 673K | 901K |
| R&D % of Revenue | 82.02% | 175.01% | 89.93% | 114.89% | 30.71% | 8.46% | 3.39% | 2.84% | 2.06% | - |
| Other Operating Expenses | 326.61K | 0 | 9.95K | 71.21K | 7.97M | 784K | 766K | 752K | 789K | 587K |
| Operating Income | -3.32M▲ 0% | -3.82M▼ 15.3% | -7.18M▼ 87.7% | -8.79M▼ 22.5% | -25.2M▼ 186.5% | -14.14M▲ 43.9% | -8.95M▲ 36.7% | -540K▲ 94.0% | 5.42M▲ 1103.1% | 6.85M▲ 0% |
| Operating Margin % | -241.01% | -517.85% | -388.11% | -854.87% | -621.15% | -108.7% | -53.47% | -2.65% | 16.6% | 16.6% |
| Operating Income Growth % | 25.27% | -15.32% | -87.75% | -22.48% | -186.55% | 43.88% | 36.7% | 93.97% | 1103.15% | - |
| EBITDA | -2.99M | -3.8M | -7.16M | -8.72M | -24.19M | -12.91M | -8M | 488K | 6.56M | 8.16M |
| EBITDA Margin % | -217.28% | -514.59% | -386.9% | -847.95% | -596.2% | -99.2% | -47.78% | 2.39% | 20.11% | 19.77% |
| EBITDA Growth % | 27.56% | -27.11% | -88.35% | -21.87% | -177.29% | 46.64% | 38.01% | 106.1% | 1244.67% | 65.98% |
| D&A (Non-Cash Add-back) | 326.61K | 24.07K | 22.33K | 71.21K | 1.01M | 1.24M | 952K | 1.03M | 1.15M | 1.31M |
| EBIT | -3.32M | -4.4M | -7.14M | -8.59M | -28.4M | -20.14M | 3.84M | -10.18M | -17.71M | 1.06M |
| Net Interest Income | -854.98K | -1.14M | -4.5M | -1.84M | -2.54M | -7.09M | -14.13M | -15.62M | -13.64M | -8.08M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 854.98K | 1.14M | 4.5M | 1.84M | 2.54M | 7.09M | 14.13M | 15.62M | 13.64M | 8.08M |
| Other Income/Expense | -3.12M | -1.71M | -4.45M | -1.64M | -5.74M | -13.09M | -1.34M | -25.26M | -36.76M | -13.87M |
| Pretax Income | -6.44M▲ 0% | -5.54M▲ 14.0% | -11.63M▼ 110.0% | -10.43M▲ 10.3% | -30.94M▼ 196.6% | -27.23M▲ 12.0% | -10.29M▲ 62.2% | -25.8M▼ 150.7% | -31.34M▼ 21.5% | -7.02M▲ 0% |
| Pretax Margin % | -467.93% | -749.86% | -628.7% | -1013.86% | -762.56% | -209.31% | -61.47% | -126.5% | -96.05% | -17% |
| Income Tax | 3.12M | 0 | 45.01K | 0 | 0 | 28K | 2K | 4K | 27K | 27K |
| Effective Tax Rate % | -48.47% | 0% | -0.39% | 0% | 0% | -0.1% | -0.02% | -0.02% | -0.09% | -0.38% |
| Net Income | -6.44M▲ 0% | -5.54M▲ 14.0% | -11.63M▼ 110.0% | -10.43M▲ 10.3% | -30.94M▼ 196.6% | -27.26M▲ 11.9% | -10.29M▲ 62.2% | -25.81M▼ 150.7% | -31.37M▼ 21.6% | -7.04M▲ 0% |
| Net Margin % | -467.93% | -749.86% | -628.7% | -1013.86% | -762.56% | -209.52% | -61.48% | -126.52% | -96.13% | -17.06% |
| Net Income Growth % | -33.86% | 13.99% | -110.03% | 10.33% | -196.62% | 11.89% | 62.24% | -150.72% | -21.56% | -1710.8% |
| Net Income (Continuing) | -6.41M | -5.54M | -11.63M | -10.43M | -30.94M | -27.26M | -10.29M | -25.81M | -31.37M | -7.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -22.50▲ 0% | -15.00▲ 33.3% | -29.17▼ 94.5% | -19.26▲ 34.0% | -30.68▼ 59.3% | -19.72▲ 35.7% | -7.02▲ 64.4% | -12.19▼ 73.6% | -7.03▲ 42.3% | -0.77▲ 0% |
| EPS Growth % | 25% | 33.33% | -94.45% | 33.95% | -59.26% | 35.72% | 64.4% | -73.65% | 42.33% | -1484.94% |
| EPS (Basic) | -22.50 | -15.00 | -29.17 | -19.26 | -30.68 | -19.72 | -7.02 | -12.19 | -7.03 | - |
| Diluted Shares Outstanding | 286.99K | 370.24K | 398.77K | 541.44K | 1.01M | 1.38M | 1.47M | 2.12M | 4.46M | 9.14M |
| Basic Shares Outstanding | 286.99K | 370.24K | 398.77K | 541.44K | 1.01M | 1.38M | 1.47M | 2.12M | 4.46M | 8.57M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
SNWV Balance Sheet
SANUWAVE Health, Inc. (SNWV) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 914.15K | 1.2M | 1.08M | 2.5M | 7.93M | 4.4M | 6.62M | 9.78M | 18.4M | 22.63M |
| Cash & Short-Term Investments | 133.57K | 730.18K | 364.55K | 1.76M | 2.44M | 619K | 1.15M | 1.8M | 10.24M | 9.6M |
| Cash Only | 133.57K | 730.18K | 364.55K | 1.76M | 2.44M | 619K | 1.15M | 1.8M | 10.24M | 9.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 460.8K | 152.52K | 236K | 75.54K | 2.36M | 2.42M | 4.03M | 3.31M | 3.33M | 4.62M |
| Days Sales Outstanding | 122.23 | 75.38 | 46.56 | 26.8 | 211.96 | 67.75 | 87.84 | 59.3 | 37.23 | 34.62 |
| Inventory | 231.95K | 231.53K | 357.82K | 542.96K | 2.96M | 1.04M | 868K | 2.95M | 4.15M | 6.81M |
| Days Inventory Outstanding | 149.81 | 349.25 | 188.28 | 367.73 | 928.52 | 76.13 | 73.15 | 178.48 | 187.33 | 221.56 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 570K | 1.72M | 682K | 1.6M |
| Total Non-Current Assets | 90.72K | 74.29K | 94.25K | 877.63K | 15.1M | 14.22M | 13.25M | 12.63M | 11.72M | 12.97M |
| Property, Plant & Equipment | 76.94K | 60.37K | 77.75K | 835.7K | 1.27M | 1.01M | 856K | 938K | 732K | 2.42M |
| Fixed Asset Turnover | 17.89x | 12.23x | 23.79x | 1.23x | 3.20x | 12.86x | 19.56x | 21.75x | 44.58x | 24.99x |
| Goodwill | 0 | 0 | 0 | 0 | 7.26M | 7.26M | 7.26M | 7.26M | 7.26M | 7.26M |
| Intangible Assets | 0 | 0 | 0 | 0 | 6.54M | 5.84M | 5.14M | 4.43M | 3.73M | 3.2M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13.79K | 13.92K | 16.49K | 41.93K | 28K | 106K | 0 | 0 | 0 | 79K |
| Total Assets | 1M▲ 0% | 1.28M▲ 27.3% | 1.18M▼ 7.9% | 3.38M▲ 187.2% | 23.03M▲ 580.9% | 18.62M▼ 19.1% | 19.87M▲ 6.7% | 22.42M▲ 12.8% | 30.12M▲ 34.4% | 35.6M▲ 0% |
| Asset Turnover | 1.37x | 0.58x | 1.57x | 0.30x | 0.18x | 0.70x | 0.84x | 0.91x | 1.08x | 1.27x |
| Asset Growth % | 4.85% | 27.26% | -7.9% | 187.16% | 580.87% | -19.14% | 6.74% | 12.8% | 34.36% | 186.89% |
| Total Current Liabilities | 7.92M | 11.16M | 16.49M | 12.42M | 36.17M | 56.26M | 60.22M | 64.75M | 42.34M | 19.58M |
| Accounts Payable | 712.96K | 1.5M | 1.59M | 1.44M | 4.45M | 7.64M | 4.4M | 5.71M | 3.73M | 3.99M |
| Days Payables Outstanding | 460.48 | 2.26K | 838.03 | 974.88 | 1.4K | 559.58 | 370.82 | 345.04 | 168.32 | 157.49 |
| Short-Term Debt | 5.41M | 6.05M | 10.79M | 6.17M | 16.59M | 27.12M | 38.54M | 29.96M | 25.3M | 5.82M |
| Deferred Revenue (Current) | 18.81K | 13.32K | 131.8K | 66.58K | 32K | 48K | 60K | 92K | 193K | 859K |
| Other Current Liabilities | 1.71M | 2M | 3.63M | 1.61M | 11.42M | 13.97M | 8.45M | 19.18M | 10.67M | 8.47M |
| Current Ratio | 0.12x | 0.11x | 0.07x | 0.20x | 0.22x | 0.08x | 0.11x | 0.15x | 0.43x | 0.43x |
| Quick Ratio | 0.09x | 0.09x | 0.04x | 0.16x | 0.14x | 0.06x | 0.10x | 0.11x | 0.34x | 0.34x |
| Cash Conversion Cycle | -188.44 | -1.83K | -603.19 | -580.35 | -258.58 | -415.69 | -209.83 | -107.26 | 56.24 | 98.7 |
| Total Non-Current Liabilities | 0 | 0 | 46.74K | 1.03M | 571K | 1.31M | 668K | 839K | 491K | 18.95M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 143K | 875K | 0 | 0 | 0 | 17.73M |
| Capital Lease Obligations | 0 | 0 | 0 | 457.02K | 391K | 118K | 438K | 492K | 191K | 2.64M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 28K | 28K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -28K | 0 | 0 | 34K |
| Total Liabilities | 7.92M | 11.16M | 16.53M | 13.45M | 36.74M | 57.58M | 60.88M | 65.59M | 42.84M | 38.53M |
| Total Debt | 5.52M | 6.05M | 10.79M | 6.92M | 17.58M | 28.39M | 38.98M | 30.45M | 25.5M | 24.45M |
| Net Debt | 5.39M | 5.32M | 10.43M | 5.16M | 15.14M | 27.77M | 37.82M | 28.66M | 15.26M | 14.85M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | -8.34x |
| Debt / EBITDA | - | - | - | - | - | - | - | 62.41x | 3.89x | 3.00x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | 58.72x | 2.33x | 2.33x |
| Interest Coverage | -3.88x | -3.36x | -1.60x | -4.79x | -9.92x | -1.99x | -0.63x | -0.03x | 0.40x | 0.13x |
| Total Equity | -6.91M▲ 0% | -9.88M▼ 43.0% | -15.36M▼ 55.4% | -10.06M▲ 34.5% | -13.72M▼ 36.3% | -38.96M▼ 184.0% | -41.01M▼ 5.3% | -43.18M▼ 5.3% | -12.72M▲ 70.5% | -2.93M▲ 0% |
| Equity Growth % | -17.59% | -42.96% | -55.41% | 34.47% | -36.31% | -183.99% | -5.27% | -5.29% | 70.55% | 292.05% |
| Book Value per Share | -24.08 | -26.69 | -38.51 | -18.59 | -13.60 | -28.18 | -27.99 | -20.40 | -2.85 | -0.32 |
| Total Shareholders' Equity | -6.91M | -9.88M | -15.36M | -10.06M | -13.72M | -38.96M | -41.01M | -43.18M | -12.72M | -2.93M |
| Common Stock | 137.22K | 139.3K | 155.66K | 293.78K | 471K | 482K | 549K | 3K | 9K | 9K |
| Retained Earnings | -99.43M | -104.97M | -116.6M | -125.75M | -156.69M | -183.95M | -194.24M | -220.05M | -251.42M | -245.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -52.07K | -43.78K | -62.87K | -62.23K | -62K | -73K | -67K | -111K | 10K | 10K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNWV Cash Flow Statement
SANUWAVE Health, Inc. (SNWV) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.2M | -1.53M | -3.62M | -6.41M | -12.72M | -6.41M | -17.17M | -4.54M | 2.46M | 2.46M |
| Operating CF Margin % | -232.51% | -207.03% | -195.73% | -623.17% | -313.48% | -49.26% | -102.55% | -22.25% | 7.52% | - |
| Operating CF Growth % | 7.89% | 52.21% | -136.84% | -77.04% | -98.39% | 49.61% | -167.89% | 73.57% | 154.1% | 152.73% |
| Net Income | -6.44M | -5.54M | -11.63M | -10.43M | -30.94M | -27.26M | -10.29M | -25.81M | -31.37M | -7.04M |
| Depreciation & Amortization | 326.61K | 24.07K | 22.33K | 71.21K | 1.01M | 1.24M | 952K | 1.03M | 1.15M | 1.31M |
| Stock-Based Compensation | 547.84K | 768.11K | 2.48M | 333.42K | 22K | 0 | 0 | 0 | 1.51M | 2.11M |
| Deferred Taxes | 2.51M | 57.6K | -115.13K | -188.34K | 0 | 28K | 2K | 4K | 0 | 0 |
| Other Non-Cash Items | 355.47K | 1.3M | 4.82M | 2.09M | 15.82M | 9.66M | -6.71M | 23.84M | 34.07M | 12.19M |
| Working Capital Changes | -496K | 1.86M | 797.85K | 1.71M | 1.37M | 9.93M | -1.12M | -3.61M | -2.9M | -7.26M |
| Change in Receivables | -412.58K | 250.68K | -22.5K | -8.6K | -2.58M | -395K | -1.75M | -53K | -486K | -1.94M |
| Change in Inventory | -29.25K | -7.08K | -123.12K | -185.13K | -553K | 1.69M | -72K | -2.8M | -1.2M | -3.38M |
| Change in Payables | 203.7K | 783.56K | 276.12K | -138.73K | 3.02M | 3.18M | -2.55M | 1.55M | -1.42M | -145K |
| Cash from Investing | -8.77K | 0 | -42.89K | -53.94K | -20.05M | -529K | 332K | 21K | -490K | 2.92M |
| Capital Expenditures | -10.36K | 0 | -42.89K | -53.94K | -53K | -529K | 1.02M | 0 | -490K | -2.08M |
| CapEx % of Revenue | 0.75% | - | 2.32% | 5.24% | 1.31% | 4.07% | 6.1% | - | 1.5% | - |
| Acquisitions | 1.59K | 0 | 0 | 0 | -20M | 0 | 332K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.59K | 0 | 0 | 0 | 0 | 0 | -1.02M | 21K | 0 | 5M |
| Cash from Financing | 3.21M | 2.12M | 3.32M | 7.86M | 33.45M | 5.12M | 17.38M | 5.21M | 6.35M | 2.13M |
| Debt Issued (Net) | 15.25K | 1.71M | 3.28M | 1.25M | 9.46M | 3.38M | 16.59M | 5.85M | -2.46M | -6.59M |
| Equity Issued (Net) | 0 | 0 | 0 | 1000K | 1000K | 0 | 100K | 0 | 1000K | 106K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 3.19M | 403.07K | 40.73K | 3.81M | 81K | 1.74M | 695K | -639K | -1.49M | 8.61M |
| Net Change in Cash | -19.36K▲ 0% | 596.61K▲ 3181.8% | -365.63K▼ 161.3% | 1.4M▲ 481.8% | 676K▼ 51.6% | -1.82M▼ 368.9% | 534K▲ 129.4% | 644K▲ 20.6% | 8.44M▲ 1210.6% | 6.34M▲ 0% |
| Free Cash Flow | -3.21M▲ 0% | -1.53M▲ 52.4% | -3.66M▼ 139.6% | -6.46M▼ 76.4% | -12.77M▼ 97.5% | -6.94M▲ 45.7% | -16.15M▼ 132.7% | -4.54M▲ 71.9% | 1.97M▲ 143.3% | -784K▲ 0% |
| FCF Margin % | -233.26% | -207.03% | -198.05% | -628.42% | -314.79% | -53.33% | -96.45% | -22.25% | 6.02% | -1.9% |
| FCF Growth % | 7.59% | 52.37% | -139.64% | -76.44% | -97.55% | 45.67% | -132.73% | 71.9% | 143.3% | -327.91% |
| FCF per Share | -11.18 | -4.13 | -9.19 | -11.94 | -12.67 | -5.02 | -11.02 | -2.14 | 0.44 | 0.44 |
| FCF Conversion (FCF/Net Income) | 0.50x | 0.28x | 0.31x | 0.61x | 0.41x | 0.24x | 1.67x | 0.18x | -0.08x | 0.11x |
| Interest Paid | 0 | 0 | 0 | 0 | 436K | 2.58M | 0 | 1.96M | 4.31M | 3.38M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNWV Key Ratios
SANUWAVE Health, Inc. (SNWV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | - | - | - | - | 59.05% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | - | 159.82% | 159.82% |
| Gross Margin | 58.93% | 67.24% | 62.51% | 47.61% | 71.36% | 61.68% | 74.13% | 70.41% | 75.23% | 77.72% |
| Net Margin | -467.93% | -749.86% | -628.7% | -1013.86% | -762.56% | -209.52% | -61.48% | -126.52% | -96.13% | -17.06% |
| Debt / Equity | - | - | - | - | - | - | - | - | - | -8.34x |
| Interest Coverage | -3.88x | -3.36x | -1.60x | -4.79x | -9.92x | -1.99x | -0.63x | -0.03x | 0.40x | 0.13x |
| FCF Conversion | 0.50x | 0.28x | 0.31x | 0.61x | 0.41x | 0.24x | 1.67x | 0.18x | -0.08x | 0.11x |
| Revenue Growth | 42.52% | -46.33% | 150.51% | -44.39% | 294.37% | 220.68% | 28.69% | 21.84% | 59.99% | 40.89% |
SNWV SEC Filings & Documents
SANUWAVE Health, Inc. (SNWV) SEC filings — annual & quarterly reports (10-K, 10-Q)
SNWV Frequently Asked Questions
SANUWAVE Health, Inc. (SNWV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SANUWAVE Health, Inc. (SNWV) reported $41.3M in revenue for fiscal year 2024.
SANUWAVE Health, Inc. (SNWV) grew revenue by 60.0% over the past year. This is strong growth.
SANUWAVE Health, Inc. (SNWV) reported a net loss of $7.0M for fiscal year 2024.
Dividend & Returns
SANUWAVE Health, Inc. (SNWV) had negative free cash flow of $0.8M in fiscal year 2024, likely due to heavy capital investments.
Explore More SNWV
SANUWAVE Health, Inc. (SNWV) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates